Merck & Co. Overview

  • Founded
  • 1891
Founded
  • Status
  • Public
  • Employees
  • 71,000
Employees
  • Stock Symbol
  • MRK
Stock Symbol
  • Investments
  • 67
  • Share Price
  • $82.46
  • (As of Wednesday Closing)

Merck & Co. General Information

Description

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
NYS
Primary Office
  • 2000 Galloping Hill Road
  • Kenilworth, NJ 07033
  • United States
+1 (908) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Merck & Co. Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$82.46 $83.19 $65.25 - $90.46 $210B 2.53B 8.95M $4.55

Merck & Co. Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 229,673,547 249,714,258 212,235,768 169,355,061
Revenue 47,347,000 46,840,000 42,294,000 40,122,000
EBITDA 17,978,000 15,735,000 13,649,000 11,566,000
Net Income 11,517,000 9,843,000 6,220,000 2,394,000
Total Assets 89,800,000 84,397,000 82,637,000 87,872,000
Total Debt 28,741,000 26,346,000 25,114,000 24,410,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Merck & Co. Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merck & Co.‘s full profile, request access.

Request a free trial

Merck & Co. Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabo
Pharmaceuticals
Kenilworth, NJ
71,000 As of 2019
00000000

00000

tetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
0000000000000
Thousand Oaks, CA
00000 As of 0000
00.000
000000000000 00.000

000 0000

sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis no
0000 000000000
Indianapolis, IN
00000 As of 0000
000000 - 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Merck & Co. Competitors (60)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amgen Formerly PE-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
000 00000 Corporation Indianapolis, IN 00000 000000 - 000
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000&0
0000000-00000 0000 Corporation New York, NY 00000 00000 000000000 00000
00000000 Corporation Basel, Switzerland 000000 000000000000
You’re viewing 5 of 60 competitors. Get the full list »

Merck & Co. Executive Team (72)

Name Title Board Seat Contact Info
Kenneth Frazier JD Chief Executive Officer and Chairman of the Board
Juan Vera Chief Executive Officer (Market Access), Spain
Richard DeLuca Jr. Executive Vice President & President
Roger Perlmutter Ph.D Executive Vice President & President
Sanat Chattopadhyay Executive Vice President & President
You’re viewing 5 of 72 executive team members. Get the full list »

Merck & Co. Board Members (22)

Name Representing Role Since
000000000 0000000 00 Self Board Member 000 0000
0000 000000 Merck & Co. Board Member 000 0000
00000 000000 Self Board Member 000 0000
0000000 0000000 00 Merck & Co. Chief Executive Officer and Chairman of the Board 000 0000
000000 0000 Self Board Member 000 0000
You’re viewing 5 of 22 board members. Get the full list »

Merck & Co. Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Merck & Co. Investments & Acquisitions (67)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 000000000000000 23-Dec-2020 000000000 Drug Discovery 00000 0000000000 00.0
00000000 18-Dec-2020 000000000000000000 00.000 Drug Discovery 00000 0000000000 00.0
0000000000 23-Nov-2020 000000000000000000 00000 Drug Discovery 00000 0000000000 00.0
00000 000000 (0000 27-Jul-2020 000000000 00000 00 0000 Buildings and Property
Yumanity Therapeutics 24-Jun-2020 Later Stage VC 000.00 Drug Discovery 00000 00000000 00.0
You’re viewing 5 of 67 investments and acquisitions. Get the full list »

Merck & Co. Subsidiaries (20)

Company Name Industry Location Founded
VelosBio Drug Discovery San Diego, CA 2017
00000 000000000000 Biotechnology Lexington, MA 0000
0000000 0000000000 Pharmaceuticals Dallas, TX 0000
00000 000000 00000 Corporate Venture Capital Kenilworth, NJ 0000
0000000000 Biotechnology Australia 0000
You’re viewing 5 of 20 subsidiaries. Get the full list »

Merck & Co. Exits (23)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 000000000 24-Jun-2020 00000 00000 00 000.00 Completed
  • 7 buyers
0000000 25-Jul-2018 00000 00000 00 00000 Completed
  • 20 buyers
00000000 0000 0000 01-Aug-2016 00000 00000 00 0000 Completed
  • 4 buyers
0000000 07-Jan-2016 00000 00000 00 000.00 Completed
  • 12 buyers
Quartet Medicine 06-Jan-2016 Corporate 0000 Completed
You’re viewing 5 of 23 exits. Get the full list »